NCT01713179View on ClinicalTrials.gov

Effects of Oral Mucolytics on Tear Film and Ocular Surface

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
In the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.
Interventions
DRUG

Ambroxol hydrochloride (Mucopect®, 60 mg, Boehringer Ingelheim)

Trial Locations (1)

150-950

Hallym University, Kangnam Sacred Heart Hospital, Seoul

All Listed Sponsors
lead

Hallym University Kangnam Sacred Heart Hospital

OTHER

NCT01713179 - Effects of Oral Mucolytics on Tear Film and Ocular Surface | Biotech Hunter | Biotech Hunter